ARK
AAKG.DE
IE000O5M6XO1
ARK Genomic Revolution UCITS ETF
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
37.41
Weighted Fwd P/E
-23.55
Avg P/FCF
29.3
Avg FCF Yield
-0.77%
Avg EV / EBITDA
565.4
Avg EV / Revenue
84.8
Avg Price-to-Book (P/B)
13.93
Avg Price-to-Sales (P/S)
111.04
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
-162.96%
Avg Debt-to-Equity (D/E)
72.71%
<50% (67.02%) 50-150% (11.44%) >150% (17.29%) Unreported (4.25%)

Profitability Analysis

33 Holdings Count
Profitable 24.94%
Profitable 24.94%
6 Holdings Count (18.18%)
Unprofitable 75.06%
27 Holdings Count (81.82%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

High Concentration (Top-Heavy)
Top 5
35.2%
Top 10
58.2%
Top 25
94.0%
50% Threshold
Top 9
The top 10 holdings account for 58.2% of the total ETF. Performance is heavily driven by a few heavyweights. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

3 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (22.6%+)
High (58.6%+)
Top (81.2%+)

Country Breakdown

Max: 90.21%
US US US
90.21%
CH CH CH
5.84%
GB GB GB
3.71%

Sector Distribution

1 Sector
Healthcare
99.76%

Industry Distribution

6 Industries
Biotechnology
39.59%
Diagnostics & Research
27.66%
Medical Devices
14.67%
Health Information Services
9.33%
Drug Manufacturers - General
4.80%
Medical Care Facilities
3.71%

Market Cap Distribution

33 Holdings Count
Mega Cap (> 200B)
(1) 4.80%
Large Cap (10B - 200B)
(4) 18.85%
Mid Cap (2B - 10B)
(11) 42.89%
Small / Micro Cap (< 2B)
(17) 33.22%
ende